The core of the Biocaldol’s technology are discrete yet closely related thermophilic microorganisms designed for the production of bioethanol integrated into a simple fermentation system that can be retrofitted to existing processes.

The Biocaldol process offers significant advantages:

• Substantially lower raw material cost and feedstock flexibility – Conventional ethanol fermentations use sugars from food crops as raw material but only convert the C6 sugars. Thus not utilising 30% of the biomass which is made up of C5 hemicellulosic sugars. Biocaldol’s novel process can also utilise the C5 sugars which are currently either burnt as waste or end up in animal feed.  These non-edible plant portions comprise of carbohydrates (normally C5 sugars) that are not in the form that can be readily fermented using conventional yeast technology without a high degree of genetic manipulation. Biocaldol’s proprietary microorganisms convert both the C6 and the C5 sugars. This allows greater availability of ‘fermentable carbohydrates’ enabling Biocaldol’s to produce ethanol at more competitive rates than existing processes. It is estimated that ethanol produced using Biocaldol’s proprietary technology would be 30%  cheaper than ethanol produced by yeast fermentation.
• More efficient fermentation – The metabolic rate of Biocaldol’s (BCTL’s) microorganism is faster than that of yeast resulting in greater production efficiency. The fermentation process has been shown to yield in excess of 0.4 g. ethanol per g. sugar from lignocellulosic feedstocks, which compares well with that of conventional yeast fermentation processes.
• Leading Technology – Biocaldol is developing unique process control parameters to allow optimisation of its microorganisms for selected crop and plant waste materials
• Environmentally friendly – Biocaldol technology uses renewable waste biomass as raw material and converts most of this into ethanol and useful by-products. The high-temperature process is energy-saving, so it will reduce carbon dioxide emissions compared with conventional ethanol fermentations.
• Product Quality – Unlike some highly engineered yeast fermentation technologies, Biocaldol’s miro-organisms have been awarded GRAS Status by the US Federal Drug Administration (FDA). GRAS status is considered to be a one of the safest classifications for microorganisms.
• Valuable by-products – All the by-products from Biocaldol’s technology have commercial applications.